Karen Sielaff
-
- interferon and immune responses 4
- Immune Response and Inflammation 3
- Immune Cell Function and Interaction 2
-
- Cytokine Signaling Pathways and Interactions 5
-
- Lymphoma Diagnosis and Treatment 3
-
- NF-κB Signaling Pathways 2
-
- Cell death mechanisms and regulation 1
-
- Respiratory viral infections research 1
- Co-authors
- Ernest C. BordenMichael HawkinsL. Andrew BallJames A. MerrittAnne P. TeitelbaumR. R. BrownPatricia L. WittR V Smalley
- Cited by
- ImmunologyOncologyGenetics
- Journals
- JNCI Journal of the National Cancer Institute (1 paper)Journal of neurosurgery (1 paper)Cancer Prevention Research (1 paper)
- Partner nations
- United StatesSwitzerlandJapan
In The Last Decade
Karen Sielaff
11 papers receiving 314 citations
Peers
Comparison fields: 5 of 68
- Immunology 116
- Oncology 112
- Genetics 32
- Pathology and Forensic Medicine 54
- Biochemistry 19
Countries citing papers authored by Karen Sielaff
This map shows the geographic impact of Karen Sielaff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Sielaff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Sielaff more than expected).
Fields of papers citing papers by Karen Sielaff
This network shows the impact of papers produced by Karen Sielaff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Sielaff. The network helps show where Karen Sielaff may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Karen Sielaff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 71 | |
| 2 | In vivo priming effects of interferon-beta ser on NK activity of peripheral blood mononuclear cells in cancer patients. | 1995 | 5 |
| 3 | 1992 | 15 | |
| 4 | 1989 | 11 | |
| 5 | 1989 | 63 | |
| 6 | Phase I trial of human lymphoblastoid interferon with whole body hyperthermia in advanced cancer. | 1989 | 24 |
| 7 | A phase I trial of interferon-alpha-2a plus cyclophosphamide, vincristine, prednisone, and doxorubicin. | 1989 | 1 |
| 8 | 1988 | 25 | |
| 9 | 1986 | 34 | |
| 10 | 1986 | 32 | |
| 11 | Phase I evaluation of a synthetic mutant of beta-interferon. | 1985 | 52 |
About Karen Sielaff
Karen Sielaff is a scholar working on Immunology, Oncology and Critical Care and Intensive Care Medicine, having authored 11 papers that have together received 333 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (5 papers), interferon and immune responses (4 papers), Immune Response and Inflammation (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Immune Cell Function and Interaction (2 papers), NF-κB Signaling Pathways (2 papers), Cell death mechanisms and regulation (1 paper) and Respiratory viral infections research (1 paper). The work is most often cited by research in Immunology (116 citations), Oncology (112 citations) and Genetics (32 citations). Karen Sielaff has collaborated with scholars based in United States, Switzerland and Japan. Frequent co-authors include Ernest C. Borden, Michael Hawkins, L. Andrew Ball, James A. Merritt, Anne P. Teitelbaum, R. R. Brown, Patricia L. Witt, R V Smalley, Daniel A. Goldstein and S. P. Datta. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Journal of neurosurgery and Cancer Prevention Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.